Lithium Controlled-Release and Extended-Release Tablets and Lorabid Pulvules
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Lorabid Pulvules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: loracarbef
Brand name:
Synonyms: Lorabid Pulvules (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Loracarbef
- Lithium Controlled-Release and Extended-Release Tablets-Loratadine
- Lithium Controlled-Release and Extended-Release Tablets-Loratadine and pseudoephedrine
- Lithium Controlled-Release and Extended-Release Tablets-Loratadine Capsules and Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Loratadine Chewable Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Loratadine Liquid
- Lorabid Pulvules-Lithium ER
- Lorabid Pulvules-Lithium Oral Solution
- Lorabid Pulvules-Lithium Salts
- Lorabid Pulvules-Lithium Syrup and Oral Solution
- Lorabid Pulvules-Lithobid
- Lorabid Pulvules-Lithostat